Phenyl carbamates of amino acids as prodrug forms for protecting phenols against first-pass metabolism
- 1 March 1992
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 81 (2-3) , 253-261
- https://doi.org/10.1016/0378-5173(92)90017-v
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Enhanced bioavailability of a new class of dopamine D-1 antagonists following oral administration of their carbamic acid ester prodrugs to dogsInternational Journal of Pharmaceutics, 1992
- Carbamate Ester Prodrugs of Dopaminergic Compounds: Synthesis, Stability, and BioconversionJournal of Pharmaceutical Sciences, 1991
- Epimerization and racemization of some chiral drugs in the presence of human serum albumin.CHEMICAL & PHARMACEUTICAL BULLETIN, 1990
- Naltrexone-3-salicylate (a Prodrug of Naltrexone): Synthesis and Pharmacokinetics in DogsPharmaceutical Research, 1988
- Prodrugs for Improved Oral β-Estradiol BioavailabilityPharmaceutical Research, 1988
- Prodrugs for improved oral nalbuphine bioavailability: inter-species differences in the disposition of nalbuphine and its acetylsalicylate and anthranilate estersInternational Journal of Pharmaceutics, 1987
- Improvement of the Oral Bioavailability of Naltrexone in Dogs: A Prodrug ApproachJournal of Pharmaceutical Sciences, 1987
- Drug Metabolism by the Gastrointestinal MucosaClinical Pharmacokinetics, 1981
- Elimination–addition mechanism for the hydrolysis of carbamates. Trapping of an isocyanate intermediate by an o-amino-groupJournal of the Chemical Society, Perkin Transactions 2, 1973
- Reaction of plasma albumin with i-naphthyl N-methylcarbamate and certain other estersBiochimica et Biophysica Acta, 1959